Search - tctmd.com

Displaying 1 - 20 of 20

Sort: Relevancy | Date

News Opinion CV Team Dispatch

October 2025 Dispatch for the CV Team

L.A. McKeown

October 25, 2025

News Daily News

FDA Approves Triple Therapy Polypill for High Blood Pressure

Michael O'Riordan

June 10, 2025

News Daily News

CV Screening, Care at UK Football Club Made Inroads Against HF

Caitlin E. Cox

March 07, 2025

News Daily News

Use of Secondary CVD Prevention Meds Still Meager Worldwide

Caitlin E. Cox

February 03, 2025

News Conference News AHA 2024

Indian Patients Do Well on Dual-Combination Pills for Hypertension: TOPSPIN

Caitlin E. Cox

November 22, 2024

News Daily News

Hypertension Drug Effects Differ From Person to Person, PHYSIC Trial Shows

L.A. McKeown

April 12, 2023

News Opinion CV Team Dispatch

February 2023 News Roundup

L.A. McKeown

February 15, 2023

News Daily News

Query Use of Nontraditional Therapies for HF at Every Visit: AHA Statement

Todd Neale

December 09, 2022

News Daily News

Certain CV Meds Tied to Higher MI Risk in Warmer Weather

Caitlin E. Cox

August 04, 2022

News Opinion Off Script

To Save a Dying Mother

Kathryn J. Lindley, MD

June 28, 2022

News Daily News

Comorbidities May Drive PAD Procedural Outcomes in Black Patients

L.A. McKeown

June 23, 2022

News Daily News

Upping Generic CV Drug Scripts Could Save Medicare and Patients Millions

L.A. McKeown

December 17, 2021

News Daily News

Skin Cancer Risk With Common Diuretics Confirmed Anew

L.A. McKeown

April 14, 2021

News Daily News

AHA Highlights Unique Needs of Opioid-Associated Cardiac Arrest

Shelley Wood

March 18, 2021

News Daily News

ACE Inhibitors, ARBs: Still No Link to COVID-19 Risks, New Analyses Show

Michael O'Riordan

December 21, 2020

News Conference News AHA 2020

One Pill to Treat Them All: Polycap Strategy Sees Success in TIPS-3

Michael O'Riordan

November 13, 2020

News Conference News ESC 2020

Insights From a Deep Dive Into CV Risk Among Hospitalized COVID-19 Patients

Shelley Wood

September 04, 2020

News Daily News

GATEWAY at 3 Years: Bariatric Surgery Continues to Reduce Need for Antihypertensive Drugs

L.A. McKeown

August 31, 2020

News Conference News ESC 2019

Nonphysician, Community Intervention Curbs CV Risk Factors: HOPE 4

Michael O'Riordan

September 02, 2019

News Conference News ACC 2019

Amlodipine the Key Component in Dual BP Therapy in Sub-Saharan Africa: CREOLE

Caitlin E. Cox

March 25, 2019

Advertisement

October 2025 Dispatch for the CV Team

FDA Approves Triple Therapy Polypill for High Blood Pressure

CV Screening, Care at UK Football Club Made Inroads Against HF

Use of Secondary CVD Prevention Meds Still Meager Worldwide

Indian Patients Do Well on Dual-Combination Pills for Hypertension: TOPSPIN

Hypertension Drug Effects Differ From Person to Person, PHYSIC Trial Shows

February 2023 News Roundup

Query Use of Nontraditional Therapies for HF at Every Visit: AHA Statement

Certain CV Meds Tied to Higher MI Risk in Warmer Weather

To Save a Dying Mother

Comorbidities May Drive PAD Procedural Outcomes in Black Patients

Upping Generic CV Drug Scripts Could Save Medicare and Patients Millions

Skin Cancer Risk With Common Diuretics Confirmed Anew

AHA Highlights Unique Needs of Opioid-Associated Cardiac Arrest

ACE Inhibitors, ARBs: Still No Link to COVID-19 Risks, New Analyses Show

One Pill to Treat Them All: Polycap Strategy Sees Success in TIPS-3

Insights From a Deep Dive Into CV Risk Among Hospitalized COVID-19 Patients

GATEWAY at 3 Years: Bariatric Surgery Continues to Reduce Need for Antihypertensive Drugs

Nonphysician, Community Intervention Curbs CV Risk Factors: HOPE 4

Amlodipine the Key Component in Dual BP Therapy in Sub-Saharan Africa: CREOLE

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content